These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 24508483)

  • 1. Can quantitative EEG measures predict clinical outcome in subjects at Clinical High Risk for psychosis? A prospective multicenter study.
    van Tricht MJ; Ruhrmann S; Arns M; Müller R; Bodatsch M; Velthorst E; Koelman JH; Bour LJ; Zurek K; Schultze-Lutter F; Klosterkötter J; Linszen DH; de Haan L; Brockhaus-Dumke A; Nieman DH
    Schizophr Res; 2014 Mar; 153(1-3):42-7. PubMed ID: 24508483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative electroencephalography as a biomarker for proneness toward developing psychosis.
    Fuggetta G; Bennett MA; Duke PA; Young AM
    Schizophr Res; 2014 Mar; 153(1-3):68-77. PubMed ID: 24508484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EEG spectral power and negative symptoms in at-risk individuals predict transition to psychosis.
    Zimmermann R; Gschwandtner U; Wilhelm FH; Pflueger MO; Riecher-Rössler A; Fuhr P
    Schizophr Res; 2010 Nov; 123(2-3):208-16. PubMed ID: 20850950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Auditory P300 as a predictor of short-term prognosis in subjects at clinical high risk for psychosis.
    Kim M; Lee TY; Lee S; Kim SN; Kwon JS
    Schizophr Res; 2015 Jul; 165(2-3):138-44. PubMed ID: 25956629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European prediction of psychosis study.
    Ruhrmann S; Schultze-Lutter F; Salokangas RK; Heinimaa M; Linszen D; Dingemans P; Birchwood M; Patterson P; Juckel G; Heinz A; Morrison A; Lewis S; von Reventlow HG; Klosterkötter J
    Arch Gen Psychiatry; 2010 Mar; 67(3):241-51. PubMed ID: 20194824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptomatic and functional remission of subjects at clinical high risk for psychosis: a 2-year naturalistic observational study.
    Lee TY; Kim SN; Correll CU; Byun MS; Kim E; Jang JH; Kang DH; Yun JY; Kwon JS
    Schizophr Res; 2014 Jul; 156(2-3):266-71. PubMed ID: 24815568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Strauss and Carpenter Prognostic Scale in subjects clinically at high risk of psychosis.
    Nieman DH; Velthorst E; Becker HE; de Haan L; Dingemans PM; Linszen DH; Birchwood M; Patterson P; Salokangas RK; Heinimaa M; Heinz A; Juckel G; von Reventlow HG; Morrison A; Schultze-Lutter F; Klosterkötter J; Ruhrmann S;
    Acta Psychiatr Scand; 2013 Jan; 127(1):53-61. PubMed ID: 22775300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Environmental factors and social adjustment as predictors of a first psychosis in subjects at ultra high risk.
    Dragt S; Nieman DH; Veltman D; Becker HE; van de Fliert R; de Haan L; Linszen DH
    Schizophr Res; 2011 Jan; 125(1):69-76. PubMed ID: 20884179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of levetiracetam monotherapy on background EEG activity and cognition in drug-naïve epilepsy patients.
    Cho JR; Koo DL; Joo EY; Yoon SM; Ju E; Lee J; Kim DY; Hong SB
    Clin Neurophysiol; 2012 May; 123(5):883-91. PubMed ID: 22000706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of functional outcome in individuals at high clinical risk for psychosis at six years follow-up.
    Brandizzi M; Valmaggia L; Byrne M; Jones C; Iwegbu N; Badger S; McGuire P; Fusar-Poli P
    J Psychiatr Res; 2015 Jun; 65():115-23. PubMed ID: 25837413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of psychosis by mismatch negativity.
    Bodatsch M; Ruhrmann S; Wagner M; Müller R; Schultze-Lutter F; Frommann I; Brinkmeyer J; Gaebel W; Maier W; Klosterkötter J; Brockhaus-Dumke A
    Biol Psychiatry; 2011 May; 69(10):959-66. PubMed ID: 21167475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Axis I diagnoses and transition to psychosis in clinical high-risk patients EPOS project: prospective follow-up of 245 clinical high-risk outpatients in four countries.
    Salokangas RK; Ruhrmann S; von Reventlow HG; Heinimaa M; Svirskis T; From T; Luutonen S; Juckel G; Linszen D; Dingemans P; Birchwood M; Patterson P; Schultze-Lutter F; Klosterkötter J;
    Schizophr Res; 2012 Jul; 138(2-3):192-7. PubMed ID: 22464922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting Remission in Subjects at Clinical High Risk for Psychosis Using Mismatch Negativity.
    Kim M; Lee TH; Yoon YB; Lee TY; Kwon JS
    Schizophr Bull; 2018 Apr; 44(3):575-583. PubMed ID: 29036493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resting EEG in psychosis and at-risk populations--a possible endophenotype?
    Ranlund S; Nottage J; Shaikh M; Dutt A; Constante M; Walshe M; Hall MH; Friston K; Murray R; Bramon E
    Schizophr Res; 2014 Mar; 153(1-3):96-102. PubMed ID: 24486144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting psychosis in a general adolescent psychiatric sample.
    Lindgren M; Manninen M; Kalska H; Mustonen U; Laajasalo T; Moilanen K; Huttunen M; Cannon TD; Suvisaari J; Therman S
    Schizophr Res; 2014 Sep; 158(1-3):1-6. PubMed ID: 25015028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurocognitive function as a possible marker for remission from clinical high risk for psychosis.
    Lee TY; Shin YS; Shin NY; Kim SN; Jang JH; Kang DH; Kwon JS
    Schizophr Res; 2014 Mar; 153(1-3):48-53. PubMed ID: 24529365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a stage-dependent prognostic model to predict psychosis in ultra-high-risk patients seeking treatment for co-morbid psychiatric disorders.
    Ising HK; Ruhrmann S; Burger NA; Rietdijk J; Dragt S; Klaassen RM; van den Berg DP; Nieman DH; Boonstra N; Linszen DH; Wunderink L; Smit F; Veling W; van der Gaag M
    Psychol Med; 2016 Jul; 46(9):1839-51. PubMed ID: 26979398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features.
    Yung AR; Phillips LJ; Yuen HP; McGorry PD
    Schizophr Res; 2004 Apr; 67(2-3):131-42. PubMed ID: 14984872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychosis prediction: stratification of risk estimation with information-processing and premorbid functioning variables.
    Nieman DH; Ruhrmann S; Dragt S; Soen F; van Tricht MJ; Koelman JH; Bour LJ; Velthorst E; Becker HE; Weiser M; Linszen DH; de Haan L
    Schizophr Bull; 2014 Nov; 40(6):1482-90. PubMed ID: 24142369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction Models of Functional Outcomes for Individuals in the Clinical High-Risk State for Psychosis or With Recent-Onset Depression: A Multimodal, Multisite Machine Learning Analysis.
    Koutsouleris N; Kambeitz-Ilankovic L; Ruhrmann S; Rosen M; Ruef A; Dwyer DB; Paolini M; Chisholm K; Kambeitz J; Haidl T; Schmidt A; Gillam J; Schultze-Lutter F; Falkai P; Reiser M; Riecher-Rössler A; Upthegrove R; Hietala J; Salokangas RKR; Pantelis C; Meisenzahl E; Wood SJ; Beque D; Brambilla P; Borgwardt S;
    JAMA Psychiatry; 2018 Nov; 75(11):1156-1172. PubMed ID: 30267047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.